Similarly, in esophageal cancer, knocking down the expression of TP73-AS1 in EC9706 and KYSE30 cells leads to a decrease in the expression of BHD2, thereby enhancing the drug sensitivity of esophageal cancer cells to 5-fluorouracil and cisplatin [33]. Here, PRDM10 is linked to esophageal cancer.